Insider Transactions in Q2 2022 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,346
-49.58%
|
$65,422
$7.73 P/Share
|
|
Jun 14
2022
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,850
+50.0%
|
-
|
|
Jun 14
2022
|
Jean Marc Bellemin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,346
-49.58%
|
$65,422
$7.73 P/Share
|
|
Jun 14
2022
|
Jean Marc Bellemin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,850
+50.0%
|
-
|
|
Jun 14
2022
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,809
-34.58%
|
$47,663
$7.73 P/Share
|
|
Jun 14
2022
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,690
+50.0%
|
-
|
|
Jun 01
2022
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$6,000
$6.44 P/Share
|
|
Jun 01
2022
|
Wayne P. Rothbaum Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+5.84%
|
$3,000,000
$6.43 P/Share
|
|
May 31
2022
|
Wayne P. Rothbaum Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+6.2%
|
$3,000,000
$6.77 P/Share
|
|
May 31
2022
|
Michael Weiser Director |
BUY
Open market or private purchase
|
Direct |
10,000
+4.27%
|
$60,000
$6.8 P/Share
|
|
May 31
2022
|
Ryan D Maynard Director |
BUY
Open market or private purchase
|
Direct |
7,500
+50.0%
|
$45,000
$6.75 P/Share
|
|
May 31
2022
|
Merrill A Mcpeak Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+4.37%
|
$60,000
$6.8 P/Share
|
|
May 31
2022
|
Merrill A Mcpeak Director |
BUY
Open market or private purchase
|
Direct |
10,000
+33.17%
|
$60,000
$6.84 P/Share
|